Rare but serious gastrointestinal complications have been reported in post-marketing surveillance, including: Acute pancreatitis : If suspected, the GLP-1 agonist should be stopped immediately and not restarted if pancreatitis is confirmed Severe gastroparesis : Rare post-marketing reports of severe delayed gastric emptying Intestinal obstruction : Very rare cases reported in post-marketing surveillance Patients should be advised to seek urgent medical help via NHS 111, A&E or 999 as appropriate if they experience severe or persistent abdominal pain, persistent vomiting, abdominal distension, inability to pass stool or gas, or bloody diarrhoea whilst taking GLP-1 agonists
Regardless of which med youre assigned, all GLP-1s work best when paired with sustainable lifestyle changes (like balanced eating and consistent physical activity)
Blood Sugar Balance: Helps maintain healthy blood glucose levels that are already within the normal range
Sita = sitagliptin, BIA = brain ischemic area
Partner with Vivion, not just as a supplier but as a trusted ally in ingredient sourcing, and see firsthand the difference we bring to the table